The calendar
The stock touched an all-time low on Monday morning before recovering to 111.05 dollars, up 2.47 per cent. It sits about 30 per cent below its 150 dollar debut and about 50 per cent below its all-time high of 225.64 dollars. The first results as a listed company come after the close on 4 August. The lock-up expires on 6 August, freeing roughly 20 per cent of shares, which Cory Johnson of Epistrophy Capital put at roughly triple the current tradable float.[1]
What the market expects to see is already public: revenue of 6.87 billion dollars, an adjusted loss of 0.25 dollars a share and adjusted EBITDA of 2.03 billion dollars. Those three figures do not sit together by accident. A positive adjusted EBITDA line next to a loss at the earnings line is the signature of a company whose depreciation and financing follow a very large asset base, and the distance between the two is where the capital programme shows up in the accounts.[1]
The assumption carrying the price
One input dominates everything else here. Melissa Otto of S&P Global Visible Alpha puts capital spending at 48.7 billion dollars this year, rising to 118.4 billion dollars in the 2028 financial year. Set that against an expected quarterly revenue of 6.87 billion dollars and the arithmetic is stark: the annual spending plan is several times the revenue the company is expected to book in the quarter it is about to report. Nothing about a valuation at this level survives without a view on whether that capital earns a return above its cost, and adjusted EBITDA of 2.03 billion dollars is measured before the spending happens.[1]
The steelman for that spending is real, and it deserves stating before Tuesday rather than after. A capital programme rising from 48.7 billion dollars to 118.4 billion dollars can be defensible when it buys capacity that is already contracted, because then the spending is a receivable in disguise and the loss line is a timing artefact. The honest limit on this analysis is that all three of the quarter's figures are analyst projections rather than disclosed company numbers. The first report is precisely the event that replaces an estimate with a disclosure, which is why what it contains matters more than what it prints.[1]
What Tuesday has to contain
This gives a testable expectation for the two days between the report and the expiry. If Tuesday's release contains a capital spending plan and a contracted backlog alongside the quarter, Thursday's supply meets a market that has had two sessions to price disclosed numbers. If it contains the quarter alone, the float roughly triples against a set of outside estimates that nothing has replaced. By 31 August the answer is checkable in one line: whether the company's first report included forward capital expenditure guidance, and whether that guidance sits near the 48.7 billion dollar figure the estimate assumes.[1]